| Predicate |
Object |
| classificationCPCInventive |
http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/A61P25-20
http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/A61K31-55
http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/A61K31-00 |
| classificationIPCInventive |
http://rdf.ncbi.nlm.nih.gov/pubchem/patentipc/C07D243-18
http://rdf.ncbi.nlm.nih.gov/pubchem/patentipc/A61K31-551
http://rdf.ncbi.nlm.nih.gov/pubchem/patentipc/A61K31-55
http://rdf.ncbi.nlm.nih.gov/pubchem/patentipc/A61K31-135
http://rdf.ncbi.nlm.nih.gov/pubchem/patentipc/A61P25-20
http://rdf.ncbi.nlm.nih.gov/pubchem/patentipc/C07D243-24
http://rdf.ncbi.nlm.nih.gov/pubchem/patentipc/C07D243-16
http://rdf.ncbi.nlm.nih.gov/pubchem/patentipc/C07C213-00
http://rdf.ncbi.nlm.nih.gov/pubchem/patentipc/C07C67-00
http://rdf.ncbi.nlm.nih.gov/pubchem/patentipc/A61K31-00 |
| filingDate |
1984-11-17-04:00^^<http://www.w3.org/2001/XMLSchema#date> |
| publicationDate |
1988-03-30-04:00^^<http://www.w3.org/2001/XMLSchema#date> |
| publicationNumber |
EP-0151245-A3 |
| titleOfInvention |
Soporific comprising lorazepam |
| abstract |
A soporific containing lorazepam for oral or rectal administration, containing lorazepam and diphenhydramine or a diphenhydramine acid addition salt in the weight ratio of from 1:10 to 1:75. The especially favorable weight ratio of lorazepam to diphenhydramine is 1:20 to 1:35. The invention also relates to a process for the production of a soporific containing lorazepam and diphenhydramine. |
| priorityDate |
1984-02-08-04:00^^<http://www.w3.org/2001/XMLSchema#date> |
| type |
http://data.epo.org/linked-data/def/patent/Publication |